Skip to main content

previous disabled Page of 134
and
  1. Article

    Open Access

    Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

    Immunochemotherapy is the first-line standard for extensive-stage small-cell lung cancer (ES-SCLC). Combining the regimen with anti-angiogenesis may improve efficacy. ETER701 was a multicenter, double-blind, r...

    Ying Cheng, Jianhua Chen, Wei Zhang, Chao **e, Qun Hu, Ningning Zhou in Nature Medicine (2024)

  2. Article

    Author Correction: LINE-1 transcription activates long-range gene expression

    **ufeng Li, Luyao Bie, Yang Wang, Yaqiang Hong, Ziqiang Zhou, Yiming Fan in Nature Genetics (2024)

  3. Article

    Open Access

    Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma

    Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer. Furthermore, long noncoding RNAs (lncRNAs) have been identified as pivotal regul...

    Feng **ao, Hong Zhu, Yun Guo in Journal of Experimental & Clinical Cancer … (2024)

  4. Article

    Open Access

    Saturation genome editing of BAP1 functionally classifies somatic and germline variants

    Many variants that we inherit from our parents or acquire de novo or somatically are rare, limiting the precision with which we can associate them with disease. We performed exhaustive saturation genome editin...

    Andrew J. Waters, Timothy Brendler-Spaeth, Danielle Smith in Nature Genetics (2024)

  5. No Access

    Article

    Radiation therapy with phenotypic medicine: towards N-of-1 personalization

    In current clinical practice, radiotherapy (RT) is prescribed as a pre-determined total dose divided over daily doses (fractions) given over several weeks. The treatment response is typically assessed months a...

    Li Ming Chong, Peter Wang, V. Vien Lee, Smrithi Vijayakumar in British Journal of Cancer (2024)

  6. No Access

    Article

    A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus

    The factors driving or preventing pathological expansion of tandem repeats remain largely unknown. Here, we assessed the FGF14 (GAA)·(TTC) repeat locus in 2,530 individuals by long-read and Sanger sequencing and ...

    David Pellerin, Giulia F. Del Gobbo, Madeline Couse, Egor Dolzhenko in Nature Genetics (2024)

  7. Article

    Open Access

    Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells

    Bojana Lazovic, Hoang-Tuan Nguyen, Mohammadhassan Ansarizadeh, Leif Wigge in Angiogenesis (2024)

  8. No Access

    Article

    A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial

    This study aims to develop a stacking model for accurately predicting axillary lymph node (ALN) response to neoadjuvant chemotherapy (NAC) using longitudinal MRI in breast cancer.

    Teng Zhu, Yu-Hong Huang, Wei Li, Can-Gui Wu, Yi-Min Zhang in British Journal of Cancer (2024)

  9. Article

    Open Access

    Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways

    Angiogenesis strongly reflects poor breast cancer outcome and an important contributor to breast cancer (BC) metastasis; therefore, anti-angiogenic intervention is a potential tool for cancer treatment. Howeve...

    Danhong Wang, **aozhen Liu, Weimin Hong, Tianzheng **ao in Cancer Cell International (2024)

  10. Article

    Open Access

    Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer

    Basement membrane (BM) is an important component of the extracellular matrix, which plays an important role in the growth and metastasis of tumor cells. However, few biomarkers based on BM have been developed ...

    Xuezhou Zhang, Baoan Hong, Hongwei Li, Jiahui Zhao, Mingchuan Li, Dechao Wei in BMC Cancer (2024)

  11. Article

    Open Access

    Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer

    Tumor hypoxia is associated with prostate cancer (PCa) treatment resistance and poor prognosis. Pimonidazole (PIMO) is an investigational hypoxia probe used in clinical trials. A better understanding of the cl...

    **npei Ci, Sujun Chen, Rui Zhu, Mojgan Zarif, Rahi Jain, Wangyuan Guo in BMC Cancer (2024)

  12. Article

    Open Access

    Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis

    This study investigates the role and effectiveness of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in oral cancer, focusing on the clinical relevance of EGFR and myeloid cell leu...

    Jung-Min Han, Kyu-Young Oh, Su-Jung Choi, Won-Woo Lee, Bo-Hwan ** in Cellular Oncology (2024)

  13. Article

    Open Access

    Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation

    Cancer is characterized by dysregulated cellular metabolism. Thus, understanding the mechanisms underlying these metabolic alterations is important for develo** targeted therapies. In this study, we investig...

    **g-**ng Yang, Yu-Chen Chuang in Journal of Experimental & Clinical Cancer … (2024)

  14. Article

    Open Access

    Novel prognostic nomograms for postoperative patients with oral cavity squamous cell carcinoma in the central region of China

    Oral cavity squamous cell carcinoma (OCSCC) is the most common pathological type in oral tumors. This study intends to construct a novel prognostic nomogram model based on China populations for these resectabl...

    Xue-Lian Xu, **-Hong Xu, Jia-Qi He, Yi-Hao Li, Hao Cheng in BMC Cancer (2024)

  15. Article

    Open Access

    Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis

    Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of develo** metastases in the brain. However, research focusing on treatment strategies for hormonal r...

    Dongshao Chen, Fei Xu, Yongkui Lu, Wen **a, Caiwen Du, Dun **ong in npj Breast Cancer (2024)

  16. Article

    Open Access

    OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway

    Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated susceptibility to the development of ...

    Hongfa Wei, Wenchao Li, Leli Zeng, Ni Ding, Kuan Li, Hong Yu, Fei Jiang in Molecular Cancer (2024)

  17. No Access

    Article

    LINE-1 transcription activates long-range gene expression

    Long interspersed nuclear element-1 (LINE-1 or L1) is a retrotransposon group that constitutes 17% of the human genome and shows variable expression across cell types. However, the control of L1 expression and...

    **ufeng Li, Luyao Bie, Yang Wang, Yaqiang Hong, Ziqiang Zhou, Yiming Fan in Nature Genetics (2024)

  18. Article

    Open Access

    Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

    Hope S. Rugo, Sara M. Tolaney, Delphine Loirat, Kevin Punie in npj Breast Cancer (2024)

  19. Article

    Open Access

    Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission

    After sporadic reports of post-treatment control of HIV in children who initiated combination anti-retroviral therapy (cART) early, we prospectively studied 284 very-early-cART-treated children from KwaZulu-Na...

    Nomonde Bengu, Gabriela Cromhout, Emily Adland, Katya Govender in Nature Medicine (2024)

  20. Article

    Open Access

    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial

    Acute graft-versus-host disease (aGVHD) of the lower gastrointestinal (GI) tract is a major cause of morbidity and mortality in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT)...

    Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy in Nature Medicine (2024)

previous disabled Page of 134